ramatroban has been researched along with Nasal Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, M; Ishikawa, K; Konno, A; Maesako, K; Tanikawa, H; Terada, N; Yamakoshi, T | 1 |
| Imagawa, W; Motobayashi, Y; Saida, K | 1 |
1 review(s) available for ramatroban and Nasal Obstruction
| Article | Year |
|---|---|
[Ramatroban (Baynas): a review of its pharmacological and clinical profile].
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Airway Resistance; Animals; Capillary Permeability; Carbazoles; Clinical Trials as Topic; Humans; Nasal Cavity; Nasal Mucosa; Nasal Obstruction; Receptors, Thromboxane; Rhinitis, Allergic, Perennial; Sulfonamides | 2001 |
1 trial(s) available for ramatroban and Nasal Obstruction
| Article | Year |
|---|---|
The effect of ramatroban (BAY u 3405), a thromboxane A2 receptor antagonist, on nasal cavity volume and minimum cross-sectional area and nasal mucosal hemodynamics after nasal mucosal allergen challenge in patients with perennial allergic rhinitis.
Topics: Administration, Oral; Adult; Carbazoles; Humans; Male; Nasal Mucosa; Nasal Obstruction; Nasal Provocation Tests; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Regional Blood Flow; Rhinitis, Allergic, Perennial; Sulfonamides | 1998 |